| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.00045 | 1 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.00024 | 1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.00019 | 1 |